The global pharmaceutical equipment market size is projected to exceed $68 billion by 2025. As the worlds largest API producer, China maintains an annual equipment import demand growth rate above 12%. Industry data shows 37% of first-time importers experienced customs delays, while 29% incurred additional rectification costs due to non-compliance with technical standards.
Risk dimension analysis:
A case study of a East China pharmaceutical company importing German freeze-drying equipment in 2024 showed that professional agency services saved 17 working days in customs clearance and reduced overall costs by 23.5%. Key control points include:
It is recommended that enterprises focus on the following when selecting agency services:
Excellentforeign tradeAgents should possessTechnical regulation database,Customs risk early warning systemandSupply chain resilience solutionsThree major support systems. It is recommended to establish quarterly review mechanisms to continuously optimize the compliance, economic efficiency, and timeliness indicators of equipment introduction.
? 2025. All Rights Reserved. Shanghai ICP No. 2023007705-2 PSB Record: Shanghai No.31011502009912